Nuvation Bio Inc. (NUVB)
NYSE: NUVB · Real-Time Price · USD
4.590
+0.020 (0.44%)
At close: Mar 6, 2026, 4:00 PM EST
4.450
-0.140 (-3.05%)
After-hours: Mar 6, 2026, 7:53 PM EST
Nuvation Bio Employees
Nuvation Bio had 220 employees as of December 31, 2024. The number of employees increased by 169 or 331.37% compared to the previous year.
Employees
220
Change (1Y)
169
Growth (1Y)
331.37%
Revenue / Employee
$216,158
Profits / Employee
-$703,186
Market Cap
1.57B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 220 | 169 | 331.37% |
| Dec 31, 2023 | 51 | -2 | -3.77% |
| Dec 31, 2022 | 53 | -11 | -17.19% |
| Dec 31, 2021 | 64 | 28 | 77.78% |
| Dec 31, 2020 | 36 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Novavax | 952 |
| Agios Pharmaceuticals | 540 |
| Intellia Therapeutics | 377 |
| Vir Biotechnology | 367 |
| Nurix Therapeutics | 317 |
| Kodiak Sciences | 123 |
| AnaptysBio | 104 |
| Nanobiotix | 103 |
NUVB News
- 1 day ago - Nuvation Bio Inc. (NUVB) Presents at TD Cowen 46th Annual Health Care Conference Transcript - Seeking Alpha
- 3 days ago - Nuvation Bio Inc. Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their Losses - GlobeNewsWire
- 4 days ago - Nuvation Bio Inc. (NUVB) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 5 days ago - Nuvation Bio Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update - PRNewsWire
- 10 days ago - Nuvation Bio to Participate in Upcoming Investor Conferences - PRNewsWire
- 18 days ago - Nuvation Bio to Report Fourth Quarter and Full Year 2025 Financial Results and Provide Business Update on March 2, 2026 - PRNewsWire
- 26 days ago - Nuvation Bio Announces Pivotal Global Phase 3 SIGMA Trial (G203) for Safusidenib in IDH1-Mutant Glioma - Business Wire
- 4 weeks ago - Nuvation Bio: Rollout Data Of Ibtrozi Support A Modest Buy - Seeking Alpha